StockData
Provectus Biopharmaceuticals, Inc. logo

Provectus Biopharmaceuticals, Inc. (PVCT) stock

PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$0.05+0.00 (+0.39%)

Close on Oct 19, 2026Market cap $20.55MP/E –Yield –

Provectus Biopharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Provectus Biopharmaceuticals's price to book ratio was 5.4× on Apr 28, 2017, against 6.2× a year earlier. Over the last 5 years it ranged from 0.8× to 59.5×, with a median of 8.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2017Apr 28, 20175.4×+4.4
2016Dec 30, 20160.9×−2.3
2015Dec 31, 20153.3×−4.1
2014Dec 31, 20147.4×−31.3
2013Dec 31, 201338.7×+20.6
2012Dec 31, 201218.1×+10.8
2011Dec 30, 20117.3×–

More Provectus Biopharmaceuticals figures

See a number that looks wrong?